126 related articles for article (PubMed ID: 12715371)
1. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
[TBL] [Abstract][Full Text] [Related]
2. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
[TBL] [Abstract][Full Text] [Related]
3. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
4. Aromatase and comparative response to its inhibitors in two types of endometrial cancer.
Berstein L; Kovalevskij A; Zimarina T; Maximov S; Gershfeld E; Vasilyev D; Baisheva S; Baymakhasheva A; Thijssen JH
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):71-4. PubMed ID: 15939586
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between tumor tissue aromatase, histological pattern and reproductive status in patients with breast cancer].
Larionov AA; Uporov AV; Semiglazov VF; Berstein LM
Vopr Onkol; 1998; 44(1):37-42. PubMed ID: 9578729
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of assay of sex hormones, their receptors and enzymes involved in estrogen synthesis and metabolism in endometrial carcinoma].
Bochkareva NV; Kondakova IV; Kolomiets LA; Muntian AB; Stukanov SL; Fomina SV
Vopr Onkol; 2007; 53(3):315-20. PubMed ID: 18198614
[TBL] [Abstract][Full Text] [Related]
7. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.
de Jong PC; van de Ven J; Nortier HW; Maitimu-Smeele I; Donker TH; Thijssen JH; Slee PH; Blankenstein RA
Cancer Res; 1997 Jun; 57(11):2109-11. PubMed ID: 9187104
[TBL] [Abstract][Full Text] [Related]
9. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
10. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
11. Aromatase expression was not detected by immunohistochemistry in endometrial cancer.
Jeon YT; Park SY; Kim YB; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():70-5. PubMed ID: 17404019
[TBL] [Abstract][Full Text] [Related]
12. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
14. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.
Berstein L; Zimarina T; Kovalevskij A; Maximov S; Volkov O; Thijssen JH
Neoplasma; 2005; 52(2):115-8. PubMed ID: 15800709
[TBL] [Abstract][Full Text] [Related]
15. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
18. [Peroxidase activity in human uterine tissue: connection with clinico-morphological features of endometrial cancer].
Vasil'ev DA; Kovalenko IG; Kvachevskaia IuO; Bakhidze EV; Chepik OF; Bershteĭn LM
Vopr Onkol; 2001; 47(5):575-9. PubMed ID: 11785099
[TBL] [Abstract][Full Text] [Related]
19. [Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Bochkareva NV; Kolomiets LA; Kondakova IV; Stukanov SL; Tropina TV; Muntian AB
Vopr Onkol; 2008; 54(6):729-33. PubMed ID: 19241848
[TBL] [Abstract][Full Text] [Related]
20. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]